Skip to main content

ARK Genomic Revolution ETF (ARKG)

BATS: ARKG · IEX Real-Time Price · USD
78.25 -0.40 (-0.51%)
Sep 27, 2021 4:00 PM EDT - Market closed
Assets$7.60B
NAV$78.65
Expense Ratio0.75%
PE Ration/a
Shares Out96.66M
Dividend (ttm)$0.79
Dividend Yield1.00%
Ex-Dividend DateDec 29, 2020
1-Year Return
-
Volume2,380,215
Open78.52
Previous Close78.65
Day's Range76.64 - 78.65
52-Week Low62.29
52-Week High115.15
Beta1.57
Holdings57
Inception DateOct 31, 2014

About ARKG

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.

Asset ClassPortfolio-Multi Asset
SectorBiotech
RegionGlobal
IssuerArk Funds
Stock ExchangeBATS
Ticker SymbolARKG

Top 10 Holdings

41.89% of assets
NameSymbolWeight
Teladoc HealthTDOC6.99%
Exact SciencesEXAS5.01%
Pacific Biosciences of CaliforniaPACB4.61%
Vertex PharmaceuticalsVRTX4.16%
Fate TherapeuticsFATE4.12%
Ionis PharmaceuticalsIONS4.08%
Regeneron PharmaceuticalsREGN3.62%
Twist BioscienceTWST3.30%
Takeda PharmaceuticalTAK3.02%
AccoladeACCD2.98%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 29, 2020$0.42557Dec 31, 2020
Dec 27, 2019$1.05395Dec 31, 2019
Dec 27, 2018$0.26999Dec 31, 2018
Dec 27, 2017$0.19272Dec 29, 2017
Dec 28, 2016$0.00Jan 4, 2017
Dec 24, 2015$0.00Dec 31, 2015
Full Dividend History

News

Gilded Age of Genomics Just Getting Started

Genomics is one of the cornerstones of disruptive growth in the healthcare sector. Relevant to investors is that genomics is still in its nascent stages, indicating that there's a potentially lengthy ru...

18 hours ago - ETF Trends

Google Getting Into Genomics? It Already Is

Google parent Alphabet (NASDAQ:GOOG) has a long history of disruption and one that extends far beyond internet search and advertising. As such, it's not surprising that the stock makes appearances in ex...

Other symbols:ARKKARKQ
2 weeks ago - ETF Trends

Early Cancer Detection: Major Opportunity for Genomics Investors

Genomics is one of the epicenters of futuristic healthcare investing, and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is one of the top exchange traded funds for accessing that theme. Addi...

3 weeks ago - ETF Trends

Broad Vs Narrow Thematic ETFs

What's better: a diversity of themes or a diversity of stocks in a theme?

3 weeks ago - ETFcom

Genomics Could Again Be Prime Time Idea

As experienced investors know, it takes some patience to engage with genomics stocks. That's just the lay of the land with one of the more volatile, yet promising, growth-rich corners of the healthcare ...

1 month ago - ETF Trends

The next breakthroughs in biotech

Ali Urman, Ark Invest genomics analyst, joins Fast Money 'The Next,' to discuss future of biotech.

Other symbols:IBB
1 month ago - CNBC Television

Cathie Wood's ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 150,000 shares of Pfizer Inc.

Other symbols:PFE
1 month ago - 24/7 Wall Street

ARK ETF Investors Not Getting Seasick

In spite of rocky performance in 2021, investors are still betting on ARK Funds' bright future.

Other symbols:ARKFARKKARKQARKW
1 month ago - ETFcom

Cathie Wood's ARK Invest Buys Over 1.3 Million Shares of This Health Information Company

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 1.3 million shares of Sema4 Holdings Corp.

1 month ago - 24/7 Wall Street

How Are Genomics ETFs Responding to Q2 Earnings?

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

1 month ago - Zacks Investment Research

Cathie Wood's ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC

A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp.

Other symbols:ARKK
1 month ago - 24/7 Wall Street

Cathie Wood's ARK Invest Doubles Down on Buying This Biotech-Focused SPAC

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought nearly 2 million shares of Soaring Eagle Acquisition Corp.

Other symbols:ARKK
1 month ago - 24/7 Wall Street

Cathie Wood's ARK Invest Buys Over 4.1 Million Shares of This Biotech-Focused SPAC

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 4.1 million shares of Soaring Eagle Acquisition Corp.

1 month ago - 24/7 Wall Street

Genomics Advancements Could Aid Breast Cancer Prevention

One of the primary objectives of genomics is to make strides in areas where traditional healthcare procedures and techniques have failed or aren't generating enough in the way of advancements and improv...

1 month ago - ETF Trends

Meet the ETF That's Betting Against Cathie Wood

ARK Invest's family of exchange-traded funds (ETFs) has been a force to be reckoned with in the markets over the past few years, and with Cathie Wood at the helm, why not?

Other symbols:ARKFARKKARKQARKWARKX
1 month ago - 24/7 Wall Street

Cathie Wood's ARK Invest Buys Over 850,000 Shares of Pacific Bio

A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 850,000 shares of Pacific Biosciences of California Inc.

Other symbols:ARKK
1 month ago - 24/7 Wall Street

Cathie Wood's mission is bullish for thematic ETF investing, Amplify CEO says

The Ark Invest founder's proven ability to create alpha with thematic investing bolsters the outlook for the whole space, says Amplify CEO Christian Magoon.

1 month ago - CNBC

Q2 Growth 'Nothing Short Of Virtuous': Economist

The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn't be so pessimistic.

Other symbols:ARKK
1 month ago - Benzinga

Is This Mid-Cap Biotech Stock a Buy Now?

This mid-cap growth stock could be a long-term winner.

Other symbols:KODREGN
1 month ago - The Motley Fool

Unpacking the Potential of the Synthetic Biology Space

As an actively managed exchange traded fund, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) can more nimbly move into new healthcare frontiers than rival index-based products. Synthetic biolo...

2 months ago - ETF Trends

ARK Invest's Weak Q2 Could Be Setting Up for Something Big

ARK Invest had some of the hottest exchange-traded funds (ETFs) of 2020, with massive gains across the board.

Other symbols:ARKFARKKARKQARKWARKX
2 months ago - 24/7 Wall Street

Tech Bubble 2.0 + Inflation Tsunami: How to Play Them Now

Morgan Stanley warns investors 15% correction coming as market overvalued like dot-com days.

Other symbols:AMDNVDANVTATSLA
2 months ago - Zacks Investment Research

How Healthcare ETFs Can Get Their Swagger Back

With mergers and acquisitions activity yet to heat up, healthcare stocks are lagging the broader market to this point in 2021. The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) hasn't been immun...

2 months ago - ETF Trends

The ARKG ETF and the Intersection of All Things Tech

It's often said that disruptive technologies frequently intersect with each other. For example, cloud computing and the Internet of Things (IoT) are frequently linked to advancements in cybersecurity.

2 months ago - ETF Trends

Where Will ARK Genomic Revolution ETF Be in 5 Years?

Cathie Wood's genomics ETF is making big bets on the "Genomic Age."

Other symbols:EXASNTLANVTAPACB
2 months ago - The Motley Fool